FindTrial
Sign In

Prognostic Significance of Postoperative and Post-Adjuvant Circulating Tumor DNA in Resected Colon Cancer: A Systematic Review and Meta-Analysis

Prognostic Significance of Postoperative and Post-Adjuvant Circulating Tumor DNA in Resected Colon Cancer: A Systematic Review and Meta-Analysis - Prognostic Significance of Postoperative and Post-Adjuvant Circulating Tumor DNA in Resected Colon Cancer: A Systematic Review and Meta-Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000060788
Enrollment
1000
Registered
2026-03-01
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Interventions

None listed

Sponsors

Asakayama General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The eligibility criteria were defined as follows. Studies were included if they met all of the following conditions: (1) patients with colon cancer who underwent curative-intent surgery; (2) postoperative ctDNA testing performed using plasma samples only; and (3) an observational (prospective or retrospective cohort) or randomized controlled trial design.

Exclusion criteria

Exclusion criteria: Studies were excluded if: (1) they reported updated results from previously published cohorts without providing independent data; (2) outcome data were not extractable or were insufficient to estimate effect sizes; or (3) the primary focus was cost-effectiveness analysis rather than prognostic outcomes.

Design outcomes

Primary

MeasureTime frame
Prognostic Accuracy—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactEn Wang

Asakayama General Hospital Department of Surgery

wangen.cn@gmail.com81-72-229-4882

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026